The South Korea 3D printing medical devices market was valued at USD 173.19 Million in 2024, driven by the growing demand for personalized and patient-specific implants and the increasing integration of advanced materials in the region. The market is anticipated to grow at a CAGR of 16.20% during the forecast period of 2025-2034, with the values likely to reach USD 777.29 Million by 2034. The market benefits from rising healthcare digitization, supportive government initiatives for innovative tech adoption, and expanding R&D in custom implants. Local manufacturers are leveraging export potential amid Asia-Pacific market growth.

In 2023, Osstem Implant was the leading medical device manufacturer in South Korea with a production value of around 2.1 trillion South Korean won. This made it the only South Korean medical device manufacturer with a production value exceeding one trillion won, setting it far apart from domestic competitors. Other leading manufacturers included Samsung Medison and Dentium. WONTECH and DRGEM managed to break through into the ten biggest manufacturers that year.

Osstem Implant’s domination of the South Korean medical device market

Osstem Implant, founded in 1997 as a subsidiary of Osstem Global Co., Ltd., focuses on manufacturing dental implants, equipment, and other related supplies. The company has managed to increase its sales revenue by around 385 percent between 2014 and 2022, having achieved a revenue of over one trillion South Korean won in the previous year. That same year, international sales exceeded domestic sales, with Osstem selling medical products worth about 505.2 billion won in the larger Asian market.

Dental and medical imaging manufacturers

Many of the leading medical device manufacturers in South Korea specialize in dental products or medical imaging, such as ultrasound or x-ray technology. Both of these product types are among the leading medical devices exported by South Korea. Other in-demand export items tend to be chemicals used for various diagnostic tests.

Snapshot img

Medical Devices Market Size 2025-2029

The medical devices market size is forecast to increase by USD 223 billion at a CAGR of 6.5% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. The rise in chronic diseases, such as diabetes and cardiovascular conditions, is fueling the demand for advanced medical devices that can improve patient outcomes and quality of life. Moreover, technological advancements, including the integration of artificial intelligence and machine learning, are revolutionizing medical devices, enabling more accurate diagnoses and personalized treatments. However, this market is not without challenges. The implementation of stringent cost containment measures and declining reimbursement rates pose significant obstacles for market players. As healthcare systems seek to reduce costs, medical device manufacturers must find ways to make their products more affordable without compromising quality.
Additionally, regulatory compliance remains a critical challenge, with stringent regulations governing the design, development, and marketing of medical devices. Companies must invest heavily in research and development to ensure their products meet the highest safety and efficacy standards. To capitalize on market opportunities and navigate these challenges effectively, medical device manufacturers must stay abreast of industry trends and regulatory requirements, and focus on delivering innovative, cost-effective solutions that meet the evolving needs of healthcare providers and patients.

What will be the Size of the Medical Devices Market during the forecast period?

Request Free Sample

The market continues to evolve, driven by advancements in technology, regulatory requirements, and changing healthcare trends. Evolving patterns in the market include the integration of personalized medicine, regulatory approvals, and clinical validation in the development of new devices. Minimally invasive surgery and drug delivery systems are gaining popularity due to their ability to improve patient outcomes and reduce recovery time. Medical robotics, government agencies, and big data analytics are revolutionizing surgical procedures, while regenerative medicine and biocompatible materials are paving the way for innovative medical implants. Service and support, quality management, and machine learning are essential components of the medical device industry, ensuring patient safety and regulatory compliance.
Remote patient monitoring, distribution networks, and diagnostic imaging are transforming healthcare delivery, enabling precision medicine and digital health. Cardiovascular devices, insurance companies, contract manufacturers, and artificial intelligence are also key players in the market, contributing to research and development and supply chain management. Three-dimensional (3D) printing is revolutionizing the manufacturing process, allowing for the production of complex and customized medical devices. Wearable technology and medical implants are increasingly being adopted by healthcare providers, offering patients greater convenience and improved health outcomes. The ongoing unfolding of market activities in these areas underscores the dynamic nature of the medical devices industry.

How is this Medical Devices Industry segmented?

The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and ASCs
  Clinics
  Others


Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascular
  Orthopedic
  Diagnostic imaging
  Dental
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By End-user Insights

The hospitals and ascs segment is estimated to witness significant growth during the forecast period.

The market encompasses a diverse range of technologies and applications, with hospitals and Ambulatory Surgical Centers (ASCs) representing a significant segment. Hospitals and ASCs are major consumers of medical devices, requiring equipment for diagnosis, treatment, and patient monitoring. Advanced medical devices, such as imaging equipment, surgical instruments, patient monitoring systems, and diagnostic devices, are in high demand due to increasing healthcare expenditure by governments and private entities. The global population growth and aging demographics contribute to higher patient volumes, necessitating more medical devices to meet care demands. Regulator

The Asia-Pacific (APAC) single-use medical device reprocessing market is experiencing robust growth, driven by increasing healthcare expenditure, a rising prevalence of chronic diseases, and a growing demand for cost-effective healthcare solutions. The market's 5% CAGR signifies consistent expansion, fueled by technological advancements leading to improved reprocessing techniques and a wider adoption of reusable devices in various healthcare settings. The segmentation by device type reveals a strong presence of Class I devices (like laparoscopic instruments) and Class II devices (including pulse oximeters and catheters). China, Japan, India, and South Korea represent key regional markets, with China likely holding the largest market share due to its expanding healthcare infrastructure and burgeoning population. However, regulatory hurdles, concerns regarding sterilization efficacy, and the potential for cross-contamination pose challenges to market growth. Furthermore, the market is characterized by both established multinational players such as Medline Industries and Johnson & Johnson (Sterilmed Inc) and smaller, specialized companies focusing on innovative reprocessing technologies. The forecast period (2025-2033) anticipates continued expansion, particularly driven by increased investment in healthcare infrastructure across the region and the implementation of stricter infection control protocols in hospitals and clinics. The strategic focus of key players is shifting towards developing innovative and efficient reprocessing technologies while addressing the regulatory and safety concerns associated with the practice. This includes investments in advanced sterilization techniques, automated reprocessing systems, and improved quality control measures. Furthermore, increasing awareness of the environmental impact of single-use devices is promoting the adoption of reprocessing, creating further growth opportunities. Competition in the market is likely intense, with companies focusing on product differentiation through technological advancements, cost-effectiveness, and strong distribution networks. The market will likely witness consolidation and strategic partnerships in the coming years as companies seek to expand their market reach and enhance their technological capabilities. The overall market outlook remains positive, with considerable growth expected throughout the forecast period. Recent developments include: August 2022- Ecolab Inc. expanded its Healthcare division to serve hospitals and healthcare facilities in Southeast Asia. A leader in infection prevention solutions and services, Ecolab Healthcare, offers a comprehensive array of hygiene and infection prevention solutions for hospitals, surgical centers, and healthcare facilities. They also provide instrument & endoscopy reprocessing, surgical drapes, and environmental hand hygiene., April 2022- The 'state-of-the-art' Central Sterile Services Department (CSSD) of AIIMS Bhubaneswar received 2nd prize under the Government Health Care Organization category in the Consortium of Accredited Health Care Organizations Awareness Compliances and Excellence (CAHO-ACE) program for the year 2021.. Key drivers for this market are: Rising Significance of Medical Waste Minimization, Reprocessing Single-use Devices Results in Environment Sustainability; Cost-Saving through Reprocessing Single-use Devices. Potential restraints include: Rising Significance of Medical Waste Minimization, Reprocessing Single-use Devices Results in Environment Sustainability; Cost-Saving through Reprocessing Single-use Devices. Notable trends are: Sequential Compression Sleeves Segment is Expected to Witness Growth Over the Forecast Period.

product market has been steadily increasing over recent years, and forecasts suggest a substantial growth trajectory in the upcoming period.

ATTRIBUTES	DETAILS
STUDY PERIOD	2018-2031
BASE YEAR	2023
FORECAST PERIOD	2024-2031
HISTORICAL PERIOD	2018-2022
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Vanguard, Medtronic, Arjo (ReNu Medical), Steris Healthcare, Medline ReNewal, Innovative Health, Vitruvia Medical, Northeast Scientific, Sustainable Technologies (Cardinal Health), SteriPro Canada, SureTek Medical, Konoike Group, Avante Health Solutions, Medsalv, Soma Technology, Others
SEGMENTS COVERED	By Product Type - Catheters, Laparoscopy Instruments, Biopsy Instruments, Endoscopy Instruments, Others By Application - Cardiology, Gastroenterology, Gynecology, Arthroscopy & Orthopedics, General Surgery & Anesthesia By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

Snapshot img

Medical Device Cleaning Market Size 2025-2029

The medical device cleaning market size is forecast to increase by USD 750.4 million and is estimated to grow at a CAGR of 5.6% between 2024 and 2029.

The market is experiencing significant growth due to the increasing importance of infection control in healthcare settings. With the prevalence of healthcare-associated infections (HAIs) continuing to pose a major challenge, there is a heightened focus on implementing effective sanitization and sterilization processes for medical devices. 3M, a leading company, offers medical device cleaning products such as 3M glutarex 1L, 3M glutarex 5L, and 3M radpid multi enzyme cleaner 70500 1L.
As healthcare facilities strive to reduce their carbon footprint and minimize waste, there is a push for eco-friendly alternatives to traditional cleaning agents. However, the lack of standardized cleaning protocols across healthcare facilities presents a challenge, as each facility may have unique requirements and preferences. The market is driven by the need to prevent HAIs and ensure infection control in healthcare settings. Infection control policies mandate stringent cleaning and disinfection procedures for critical devices like endoscopes and surgical instruments.

What will be the size of Market during the forecast period?

Request Free Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.

Device

  Semi-critical
  Critical
  Non-critical


Technique

  Disinfection
  Sterilization
  Cleaning
  Others


EPA Classification

  High Level
  Intermediate Level
  Low Level


Geography

  North America

    Canada
    US


  Asia

    China
    India
    Japan
    South Korea


  Europe

    Germany
    UK
    France
    Italy


  Rest of World (ROW)

Which is the largest segment driving market growth?

The semi-critical segment is estimated to witness significant growth during the forecast period. The market is experiencing growth due to the increasing importance of semi-critical devices, such as ultrasonic cleaners, washer-disinfectors, and sterilization equipment. These devices, which contact mucous membranes or damaged skin, require thorough cleaning to prevent infection spread. The significance of infection control procedures and heightened awareness of healthcare-associated infections are driving the expansion of the semi-critical equipment market.

Get a glance at the market share of various regions. Download the PDF Sample

The semi-critical segment was the largest segment and valued at USD 962.90 million in 2019. Strict regulations and laws, including the Centers for Disease Control and Prevention (CDC) Guideline for Disinfection and Sterilization in Healthcare Facilities, further emphasize the importance of properly cleaning and disinfecting medical equipment. Collaborations between industry players and healthcare institutions are also on the rise to ensure the highest standards of cleanliness for critical devices. The market outlook for medical device cleaning solutions remains positive as the demand for effective and efficient cleaning methods continues to increase. Hence, such factors are fuelling the growth of this segment during the forecast period.

Which region is leading the market?

For more insights on the market share of various regions, Request Free Sample

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, the market is experiencing significant growth due to the increasing incidence of healthcare-associated infections (HAIs) and the heightened emphasis on infection control. This market caters to the demand for effective and efficient cleaning solutions for medical devices. The medical device cleaning market is driven by the increasing focus on non-critical, semi-critical, and critical device cleanliness. Automated cleaning systems are widely adopted, ensuring effective disinfection protocols and high-level disinfection of reusable medical devices. Key considerations include surface contamination control and endoscope cleaning, which require rigorous cleaning validation to maintain regulatory compliance and ensure patient safety in healthcare environments.

The use of specialized cleaning solutions for semi-critical devices is crucial for surgical operations. The trend towards sustainable cleaning solutions offers opportunities for innovation, while the lack of standardization presents a challenge that must be addressed to ensure consistent and effective cleaning processes. The North American ma

The South Korea respiratory devices market, valued at approximately $XXX million in 2025 (estimated based on provided CAGR and market size), is projected to experience robust growth, driven by a rising prevalence of respiratory illnesses like asthma, COPD, and sleep apnea, coupled with an aging population. Increased healthcare expenditure and government initiatives promoting better respiratory health are further fueling market expansion. Technological advancements, including the development of sophisticated, portable diagnostic and therapeutic devices, are also contributing to market growth. The segment dominated by therapeutic devices, particularly PAP devices and inhalers, reflects the increasing need for effective treatment options. However, high costs associated with advanced respiratory devices and a potential shortage of skilled healthcare professionals could pose challenges to market growth in the coming years. The market is expected to maintain a compound annual growth rate (CAGR) of 7.80% from 2025 to 2033, indicating a significant expansion opportunity for manufacturers and investors. The market is segmented by device type (diagnostic and monitoring, therapeutic), and disposables. Diagnostic and monitoring devices, including spirometers and sleep test devices, are witnessing growth due to increased early detection of respiratory issues. Within the therapeutic segment, positive airway pressure (PAP) devices are leading, reflecting the increasing prevalence of sleep apnea. The disposables segment is experiencing moderate growth, driven by the consumption of consumables used in conjunction with therapeutic devices. Key players in the South Korean market include Drägerwerk AG & Co KGaA, M I One Co Ltd, Teleflex Incorporated, HoneyNaps Co Ltd, MEKICS Co Ltd, Fisher & Paykel Healthcare Limited, iSenLAb Co LTD, and ResMed Inc. Competitive dynamics are shaping the market, with companies focusing on innovation, strategic partnerships, and product differentiation to gain market share. Recent developments include: December 2022: LG launched an electronic face mask, LG Puricare Mask, in South Korea., May 2022: Somnics, Inc. received Korea Medical Device Registration and Approval (KFDA) for iNAP One Sleep Therapy System. In addition, the company launched its iNAP product in collaboration with LMT Korea Co. Ltd.. Key drivers for this market are: Increasing Prevalence of Respiratory Disorders, such as COPD, Asthma, and Sleep Apnea, Technological Advancements and Increasing Applications in Homecare Setting. Potential restraints include: Increasing Prevalence of Respiratory Disorders, such as COPD, Asthma, and Sleep Apnea, Technological Advancements and Increasing Applications in Homecare Setting. Notable trends are: Ventilator Segment is Expected to Register Significant Growth Over the Forecast Period.

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

ATTRIBUTES	DETAILS
STUDY PERIOD	2017-2030
BASE YEAR	2024
FORECAST PERIOD	2025-2030
HISTORICAL PERIOD	2017-2024
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Donaldson Company Inc., Pall Corporation, Shenzhen Yanbixin Technology Co. Ltd., Shaoxing Carere Medical Appliance Co. Ltd., Vincent Medical Manufacturing Co. Limited, GE HealthCare, Narang Medical Limited, BOENMED, Sterimed Group, Medline Industries Inc.
SEGMENTS COVERED	By Product Type - Single-stage, Multistage By Application - Online Sales, Offline Sales By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

product market has been steadily increasing over recent years, and forecasts suggest a substantial growth trajectory in the upcoming period.

ATTRIBUTES	DETAILS
STUDY PERIOD	2018-2031
BASE YEAR	2023
FORECAST PERIOD	2024-2031
HISTORICAL PERIOD	2018-2022
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer, CSL Behring, CryoLife, Zimmer Biomet, Ferrosan Medical Devices, Medtronic, Smith & Nephew, Z-Medica, Cohera Medical, Marine Polymer, Equimedical, Others
SEGMENTS COVERED	By Product Type - Hemostasis Agents, Tissue Sealing Agents By Application - Minimally Invasive Surgery, General Surgery, Others By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

ATTRIBUTES	DETAILS
STUDY PERIOD	2017-2030
BASE YEAR	2024
FORECAST PERIOD	2025-2030
HISTORICAL PERIOD	2017-2024
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Newman Medical, Natus, Biolight Co. Ltd, Sunray Medical Apparatus, Luckcome Technology, Medgyn Products, BRAEL-Medical Equipment, Narang Medical, Jindal Medical, Mature Medical Equipment, Others
SEGMENTS COVERED	By Product Type - Hand-Held Dopplers, Desktop Dopplers By Application - Hospitals, Clinics, Household By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

The South Korean ophthalmic devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 4.20% from 2025 to 2033. This expansion is fueled by several key factors. An aging population, coupled with rising prevalence of age-related eye diseases like glaucoma and cataracts, significantly increases the demand for diagnostic and surgical ophthalmic devices. Technological advancements, particularly in minimally invasive surgical techniques and sophisticated diagnostic imaging systems like OCT scanners, are driving market adoption and improving treatment outcomes. Furthermore, increased healthcare expenditure and improved access to quality healthcare within South Korea further contribute to market growth. Government initiatives promoting preventative eye care and early detection programs also play a crucial role in expanding the market. However, certain restraints influence market trajectory. High costs associated with advanced ophthalmic devices, especially surgical equipment, can limit accessibility for some segments of the population. The market is also subject to regulatory hurdles and reimbursement policies which can impact the speed of new technology adoption. Despite these challenges, the long-term outlook for the South Korean ophthalmic devices market remains positive. The continuous development of innovative solutions, coupled with a growing awareness of eye health among the population, will likely outweigh these restraints, resulting in sustained growth throughout the forecast period. The market segments, particularly surgical devices (including glaucoma devices and intraocular lenses) and diagnostic and monitoring devices (such as OCT scanners and ophthalmoscopes), are expected to show considerable expansion, driven by the factors mentioned above. Leading companies like Alcon, Zeiss, Johnson & Johnson, and others will likely continue to dominate the market, although competition is expected to intensify with the emergence of smaller innovative players. Recent developments include: In July 2022, Baxter launched its Welch Allyn RetinaVue 100 Imager PRO in South Korea. The device was designed to make diabetic retinopathy screening simple and affordable in primary care settings., In May 2022, Visus Therapeutics Inc. and Zhaoke Ophthalmology Limited announced an exclusive licensing agreement to commercialize BRIMOCHOL PF and Carbachol PF in South Korea for the treatment of presbyopia.. Key drivers for this market are: Rising Burden of Eye Disorders, Technological Advancements. Potential restraints include: Rising Burden of Eye Disorders, Technological Advancements. Notable trends are: Lasers Segment is Expected to Show Better Growth during the Forecast Period.

Snapshot img

Implantable Medical Devices Market Size 2025-2029

The implantable medical devices market size is forecast to increase by USD 35.9 billion at a CAGR of 5.9% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of chronic illnesses and advancements in technology, particularly the adoption of 3D printing for implantable devices. However, this market faces notable challenges that require strategic navigation for companies seeking to capitalize on its potential. Regulatory hurdles, including stringent approval processes and compliance requirements, impact adoption and increase costs for manufacturers. Furthermore, high surgery costs associated with implant procedures can limit accessibility for patients, despite the benefits of these advanced medical solutions. These devices, which include insulin pumps, cosmetic implants, orthopedic implants such as knee replacements and spinal implants, ventricular assist devices, neurostimulation devices, dental implants, and implantable MRI systems, are transforming healthcare services.
To succeed in this market, companies must focus on addressing these challenges through innovative strategies, such as streamlining regulatory approvals and collaborating with healthcare providers to offer affordable financing options for patients. By staying abreast of market trends and addressing these challenges effectively, companies can capitalize on the significant growth opportunities presented by the market.

What will be the Size of the Implantable Medical Devices Market during the forecast period?

Request Free Sample

The market is experiencing significant advancements, driven by the integration of technology and biocompatible materials to enhance patient care and improve surgical precision. Informed consent processes are being augmented through digital platforms, enabling more transparent communication between healthcare providers and patients. Biocompatible coatings and bioabsorbable materials are revolutionizing device development, making implants more personalized and aligned with outcomes-based reimbursement. Precision surgery is being advanced through image-guided procedures and augmented reality, while remote diagnostics and haptic feedback facilitate connected healthcare. Value-based care and regulatory affairs are shaping the industry, driving innovation in areas such as tissue engineering, stem cell therapy, and gene therapy. Additionally, the increasing prevalence of chronic diseases like diabetes and cardiovascular conditions necessitates the development of more advanced and cost-effective implantable medical devices for chronic disease management. The market is expected to witness significant growth in the coming years, particularly in areas such as extremities, cardiac pacemakers, and insulin pumps.
Device tracking and supply chain management are becoming essential components of the healthcare ecosystem, ensuring patient safety and efficient delivery of care. Wearable technology, mobile health apps, and smart implants are transforming patient portal access and remote patient management, enabling a more proactive and personalized approach to healthcare. Industry consolidation continues to shape the landscape, with companies focusing on technology adoption, clinical research, and additive manufacturing to stay competitive. Biometric monitoring and cognitive enhancement are also emerging trends, as healthcare moves towards a more holistic and patient-centric approach. The future of implantable medical devices lies in the intersection of technology, biomaterials science, and healthcare policy, as we strive to deliver safer, more effective, and more accessible healthcare solutions.

How is this Implantable Medical Devices Industry segmented?

The implantable medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Orthopedic implants
  Cardiovascular implants
  Ophthalmic implants
  Dental implants
  Others


End-user

  Hospitals
  Clinics
  Others


Material

  Metallic
  Ceramic
  Natural
  Polymeric


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Type Insights

The orthopedic implants segment is estimated to witness significant growth during the forecast period. Implantable devices, including medical implants and orthopedic implants, are transforming healthcare through advances in digital health, precision medicine, and biocompatible materials. Orthopedic implants, such as joint replacements, are essential for treating various conditions, including knee injuries, hip fractures, spinal injuries,

Market Size and Trends: The South Korea neurology devices market was valued at XX million in 2025 and is projected to grow at a CAGR of 6.80% from 2025 to 2033. The increasing prevalence of neurological disorders, advancements in neurotechnology, and supportive government initiatives are driving market growth. The rising geriatric population, improved healthcare infrastructure, and growing awareness about neurological conditions further contribute to the market's expansion. Segment Outlook: Based on type of device, the cerebrospinal fluid management devices segment held a significant market share in 2025. Interventional neurology devices, neurosurgery devices, neurostimulation devices, and other types of devices are other key segments. The interventional neurology devices segment is expected to witness high growth due to the rising demand for minimally invasive neurological procedures. Prominent companies operating in the market include Smith & Nephew, Integra LifeSciences Corporation, Abbott Laboratories, Johnson and Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, and B Braun SE. The South Korea neurology devices market is valued at USD 1.2 billion in 2022 and is projected to reach USD 1.9 billion by 2027, exhibiting a CAGR of 9.1% during the forecast period. This growth is attributed to factors such as the rising prevalence of neurological disorders, increasing healthcare expenditure, and technological advancements. Recent developments include: In March 2022, GE Healthcare and Seoul National University Bundang Hospital (SNUBH) entered a memorandum of understanding to explore opportunities for SNUBH to leverage the Edison Digital Health Platform and related services from GE Healthcare., In July 2021, Neurolief announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion, non-invasive medical devices for the treatment of migraine and depression, in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.. Key drivers for this market are: Increase in Incidence of Neurological Disorders, Increasing R&D and Huge Investments by Private Players in Neurology Devices. Potential restraints include: High Cost of Equipment. Notable trends are: Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period.

The size of the South Korea Drug Delivery Devices Market was valued at USD 251.6 Billion in 2023 and is projected to reach USD 258.5 billion by 2032, with an expected CAGR of 7.80% during the forecast period. The South Korea Drug Delivery Devices Market entails sophisticated medical devices that deliver the dosage of drugs to patients in an organized way in order to increase treatment effectiveness and patient compliance. Some of these devices are insulin pens, inhalers, autoinjectors and infusion pumps and are used by patients with chronic illnesses such as diabetes, asthma, and cancer. The market is mainly fueled by the increasing population, mainly the senior structure of the Korean community, the increased rate of chronic diseases and the increased demand for home healthcare. Other advancement are intelligent well-being drug delivery systems where patient’s conditions can be monitored, dosages adjusted and information compiled to enhance the patient care improvements. South Korea’s market also enjoys well-established governmental policies for healthcare; this applies to the promotion of drug delivery technology and its uses throughout such therapeutic segments. Recent developments include: March 2022: Futura Medical, a company developing transdermal DermaSys drug delivery technology, entered into a licensing agreement with Menarini Korea, a subsidiary of Menarini Group, for the exclusive rights to commercialize the company's gel-based Erectile Dysfunction (ED) treatment MED3000 in South Korea., November 2022: Medicox Co., Ltd. signed an exclusive distribution contract with an oral drug delivery platform developer, ORAMED Pharmaceuticals, for distribution rights for ORAMED's oral insulin in South Korea.. Key drivers for this market are: Increased Prevalence of Chronic Diseases, Requirement of Controlled Drug Release. Potential restraints include: Risk of Infection During the Usage and Stringent Regulatory Guidelines. Notable trends are: Injectable Segment is expected to Register High Growth in the Forecast Period in the South Korea Drug Delivery Devices Market.

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

ATTRIBUTES	DETAILS
STUDY PERIOD	2017-2030
BASE YEAR	2024
FORECAST PERIOD	2025-2030
HISTORICAL PERIOD	2017-2024
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Force Manager, Salesforce, Netsuite, Veeva Multichannel CRM, Hubspot, Pipedrive, SPOTIO, LeadSquared, PatientPop, Thryv, Zoho CRM, ChannelTrace, AcuityMD, Solo Fire, Showpad, Penrod, ConnectSx, Zendesk Sell, HashMicro, Insightly, Creatio, MaximizerCRM
SEGMENTS COVERED	By Product Type - Cloud-based, On-premises By Application - Large Enterprises, SME By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

Snapshot img

Cardiovascular Medical Devices Market Size 2024-2028

The cardiovascular medical devices market size is forecast to increase by USD 19.08 billion at a CAGR of 7.2% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of cardiac conditions such as atrial fibrillation and clogged arteries. This trend is driven by the rising number of individuals with these conditions and the growth of insurance providers covering diagnostic monitoring devices. companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis. Surgical devices, including ECG, Holter monitors, event monitors, and implantable loop recorders, are essential tools for the early detection and treatment of cardiovascular diseases. However, the high cost of cardiovascular procedures remains a challenge for market growth. To stay competitive, companies must offer cost-effective solutions while maintaining the highest standards of quality and patient safety. This market analysis report provides a comprehensive overview of the market growth factors, business strategies, and challenges shaping the future of the cardiovascular medical devices industry.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market holds significant importance in the healthcare industry as these devices play a crucial role in diagnosing, monitoring, and treating various heart disorders. Heart diseases, including heart failure, cardiomyopathy, and stroke, are fatal conditions that pose a major health concern worldwide. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 17.9 million deaths in 2016. Minimally invasive procedures and advanced cardiovascular devices have revolutionized the treatment landscape, offering improved patient outcomes and reduced healthcare resources. Diagnostic monitoring devices, such as ECG and Holter monitors, enable early detection and timely intervention, thereby reducing the risk of complications and mortality.
In addition, cardiology devices, including coronary artery stents and surgical devices, have significantly contributed to the advancement of cardiovascular care. For instance, coronary artery stents help in the treatment of coronary artery diseases by improving blood flow and reducing the risk of heart attacks. Artificial intelligence (AI) is increasingly being integrated into cardiovascular devices to enhance their functionality and accuracy. AL-based ECG technology, for example, can analyze ECG data more efficiently and accurately than traditional methods, enabling early detection and diagnosis of heart conditions. The cardiovascular devices market is expected to witness steady growth due to the increasing prevalence of heart disorders and the need for advanced diagnostic and therapeutic solutions.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Diagnostic and monitoring systems
  Surgical devices


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Product Insights

The diagnostic and monitoring systems segment is estimated to witness significant growth during the forecast period.

The diagnostic and monitoring segment of the international market comprises various devices that play a vital role in evaluating heart health, identifying cardiovascular diseases (CVDs) in their initial stages, and tracking disease progression or treatment response. This segment includes devices like ECGs, which measure the electrical activity of the heart and are crucial for diagnosing arrhythmias, heart attacks, and other cardiac conditions. Furthermore, echocardiograms, which employ ultrasound technology to generate detailed images of the heart, aid in assessing structural heart diseases and evaluating heart function. Portable ECG devices, such as Holter monitors and event monitors, are also part of this segment. These devices enable continuous heart monitoring over extended durations, allowing doctors to detect irregularities that may not surface during routine ECG tests.

Get a glance at the market report of share of various segments Request Free Sample

The diagnostic and monitoring systems segment was valued at USD 21.14 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the fore

In the coming years the Asia Pacific reprocessed medical devices market is expected to reach USD 480.7 million by 2025 and is expected to steadily grow at a CAGR of 5.7% to reach USD 833.5 million by 2035. In 2024, cluster headache syndrome generated roughly USD 457.1 million in revenues.

Metric	Value
Industry Size (2025E)	USD 480.7 million
Industry Value (2035F)	USD 833.5 million
CAGR (2025 to 2035)	5.7%

Country Wise Analysis

Country	CAGR (2025 to 2035)
China	7.6%

Country	CAGR (2025 to 2035)
Japan	3.3%

Country	CAGR (2025 to 2035)
South Korea	6.6%

Country	CAGR (2025 to 2035)
India	8.1%

Country	CAGR (2025 to 2035)
Australia	2.9%

Competitive Outlook

Company Name	Estimated Market Share (%)
Stryker Corporation	(17-18)%
Medline Industries, Inc.	(14-15)%
Johnson & Johnson (Ethicon)	(11-12)%
Medtronic plc	(10-11)%
Other Companies (combined)	(43-44)%

The size of the South Korea Cardiovascular Devices market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 5.20% during the forecast period.The South Korean cardiovascular devices market will witness higher growth due to the fact of an aging population, an upsurge in cardiovascular disorders, and a rise in medical expenditure. Cardiovascular medical instruments are used in diagnosing and treating diseases relating to the heart and blood vessels. These medical instruments cover broad categories of products including pacemakers, defibrillators, heart valve, stents, as well as diagnostic instruments that include echocardiogram machines and electrocardiogram (ECG). This sense has been meteorically rising among South Koreans due to the increasing number of reported heart attacks, strokes, and other cardiovascular diseases. As a nation, it is a rapidly aging populace added with an unhealthy sedentary lifestyle and diet that is making more people vulnerable towards such diseases. An improvement in medical technology along with rising awareness toward preventive healthcare is fueling growth toward high-end cardiovascular devices. The South Korea government is taking initiatives to increase the strength of healthcare infrastructure and develop innovative medical technologies, which further supports this market. The well-structured healthcare system and regulatory framework allow new and more advanced cardiovascular devices to penetrate the country. Cooperation between local and international healthcare companies will boost growth in the market further. However, this would challenge the expansion of the market due to high costs coupled with advanced devices as well as strict regulatory procedures. Despite these challenges, the outlook of the South Korean cardiovascular devices market is sound and holds substantial growth potential in the years ahead. Recent developments include: September 2022: Osstem Implant reported the relocation of its unlisted subsidiary Osstem Cardiotec's headquarters and ramp-up to command the largest production base for cardiac stent products in Korea., August 2022: VUNO, a medical AI company, won approval from the South Korean Ministry of Food and Drug Safety for their personal ECG equipment. The portable medical device, called Hativ Pro, merely measures a user's heart rate and delivers the data to a connected mobile phone app.. Key drivers for this market are: Increasing Burden of Cardiovascular Diseases, Increased Preference for Minimally Invasive Procedures. Potential restraints include: Stringent Regulatory Policies and Product Recalls. Notable trends are: Cardiac Pacemakers Expected to Witness Healthy Growth Over the Forecast Period.

The South Korea cardiovascular devices market is experiencing robust growth, driven by a rising elderly population, increasing prevalence of cardiovascular diseases (CVDs), and rising healthcare expenditure. The market, valued at approximately $XX million in 2025 (assuming a logical estimation based on the provided CAGR of 5.20% and a study period of 2019-2033, and considering global market trends), is projected to expand significantly over the forecast period (2025-2033). Key drivers include technological advancements in minimally invasive procedures, increased adoption of advanced cardiac rhythm management devices (CRMDs) like implantable cardioverter defibrillators (ICDs) and cardiac pacemakers, and growing demand for sophisticated interventional cardiac devices. This growth is further fueled by government initiatives focused on improving healthcare infrastructure and promoting preventative healthcare measures. However, high costs associated with these advanced devices, coupled with stringent regulatory approvals, may act as restraints to some extent. The market is segmented by device type (CRMDs, interventional cardiac devices, AEDs, cardiac ablation catheters, etc.) and technology (cardiopulmonary bypass products, minimally invasive surgery, etc.). Major players like Medtronic, Boston Scientific, Abbott Laboratories, and others are actively competing in this market through product innovation and strategic partnerships. The market segmentation reveals significant growth potential within specific areas. For instance, the minimally invasive cardiac surgery segment is expected to witness substantial expansion due to its advantages of reduced recovery time and improved patient outcomes. Similarly, the demand for implantable devices like ICDs and pacemakers is likely to increase, driven by the growing geriatric population and higher incidence of heart failure. While the South Korean market is relatively smaller compared to some global counterparts, its strong economic growth and increasing focus on healthcare infrastructure are expected to create considerable opportunities for market expansion in the coming years. The ongoing research and development efforts aimed at developing innovative cardiovascular devices will also contribute to the sustained growth of this market segment. Competitive dynamics within the market are intense, with established players facing pressure from emerging companies offering cost-effective solutions. Recent developments include: September 2022: Osstem Implant reported the relocation of its unlisted subsidiary Osstem Cardiotec's headquarters and ramp-up to command the largest production base for cardiac stent products in Korea., August 2022: VUNO, a medical AI company, won approval from the South Korean Ministry of Food and Drug Safety for their personal ECG equipment. The portable medical device, called Hativ Pro, merely measures a user's heart rate and delivers the data to a connected mobile phone app.. Key drivers for this market are: Increasing Burden of Cardiovascular Diseases, Increased Preference for Minimally Invasive Procedures. Potential restraints include: Increasing Burden of Cardiovascular Diseases, Increased Preference for Minimally Invasive Procedures. Notable trends are: Cardiac Pacemakers Expected to Witness Healthy Growth Over the Forecast Period.

The South Korea Aesthetic Devices Market report segments the industry into By Type Of Device (Energy Based Aesthetic Device, Non Energy Based Aesthetic Device), By Application (Skin Resurfacing & Tightening, Body Contouring And Cellulite Reduction, Hair Removal, Tattoo Removal, Breast Augmentation, Others), and By End User (Hospital, Clinics, Home Settings). Includes historical data and five-year forecasts.